CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
The Gore® EXCLUDER® ILIAC BRANCH Endoprosthesis.device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02345005
NCT02345005N/ACompleted

Multi-centre, Observational, Post-market, Real World Registry to Assess Outcomes of Patients Treated With the Gore® EXCLUDER® ILIAC BRANCH Endoprosthesis

Rijnstate Hospital·observational·Posted Jan 26, 2015·Updated Jan 5, 2026

In Brief

An observational study evaluating The Gore® EXCLUDER® ILIAC BRANCH Endoprosthesis. for Abdominal Aortic Aneurysms and 2 related conditions. Completed, enrolled 100 participants across 8 sites in 4 countries.

Detailed Summary

This post market registry consists of a retrospective and a prospective part. The first part is a retrospective registry of all implanted IBE devices of Gore in the Netherlands after CE mark was obtained, to get an initial insight on the feasibility and safety of this procedure. The second part is to prospectively register all data on implanted IBE Gore devices, in order to gain more robust data on the efficacy of the device in maintaining hypogastric artery patency.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesItaly, Netherlands, New Zealand, Spain

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedJan 26, 2015
Enrollment StartNov 1, 2014
Primary CompletionJul 1, 2025
TodayJul 2, 2026
Enrollment to primary: 10.7 yearsPosted 11.4 years ago

Interventions

The Gore® EXCLUDER® ILIAC BRANCH Endoprosthesis.device

The Gore IBE device is a newly designed iliac branched device, that is used in combination with the widely accepted C3 Excluder endograft, for the exclusion of common iliac aneurysms and aorto-iliac aneurysms.